Product Details

RenuTend Suspension for Injection for Horses

• MA holder: Boehringer Ingelheim Vetmedica GmbH
• VM number: 04491/5064
• Territory: Great Britain
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Public Assessment Report
  • View Post Authorisation Assessment
• Date of issue: 05/05/2022
• Authorisation route: National
• Active substances:
  • Tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells (tpMSCs)
• Controlled drug: No
• Target species:
  • Horses
• Distribution category: POM-V
• Distributors:
  • Boehringer Ingelheim Vetmedica GmbH